International Clinical Psychopharmacology
Title Abbreviation
Int Clin Psychopharmacol
Electronic ISSN
1473-5857
Readership
Clinical Pharmacologists, Mental Health Evaluators, Pharmacists, Pharmacologists, Psychiatrists, Psychologists, Psychotherapists
Scope
International Clinical Psychopharmacology provides an essential link between research and clinical practice throughout psychopharmacology. It reports on studies in human subjects, both healthy volunteers and patients, which relate the effects of drugs on psychological processes.
A major objective of the journal is to publish fully refereed papers which throw light on the ways in which the study of psychotropic drugs can increase our understanding of psychopharmacology. To this end the journal publishes results of early Phase I and II studies, as well as those of controlled clinical trials of psychotropic drugs in Phase II and IV. Other topics covered include the epidemiology of psychotropic drug prescribing and drug taking, the sociology of psychotropic drugs including compliance, and research into the safety and adverse effects of these compounds.
Submitted articles undergo a preliminary review by the editor. Some articles may be returned to authors without further consideration. Those being considered for publication will undergo further assessment and peer-review by the editors and those invited to do so from a reviewer pool.
Sponsoring Association(s)
No associations affiliated with this journal
Publisher Name
Wolters Kluwer Health - Lippincott Williams & Wilkins - UK
To see more details about International Clinical Psychopharmacology,
Subscribe Now!
Impact Factor
JCR Categories/Rank
Circulation
Electronic Circulation
Submission to Acceptance
Acceptance to Online Publication
Acceptance to Print Publication
Rejection Rate
Frequency
Journal Contact
Author Submission Guidelines